期刊文献+

人类免疫缺陷病毒蛋白HIV gp120对培养的大鼠背根神经节神经元的神经毒性作用(英文) 被引量:2

NEUROTOXIC EFFECT OF HIV gp120 ON CULTURED RAT DORSAL ROOT GANGLION NEURONS
下载PDF
导出
摘要 为探讨人类免疫缺陷病毒(HIV)gp120对体外培养的大鼠背根神经节(DRG)神经元的神经毒性作用,我们建立了胎鼠DRG分散培养和器官型培养的模型。以上分散培养和器官型培养的DRG,经不同浓度(250pmol/L,1nmol/L)的HIVgp120处理(2次/7d)。分散培养的DRG细胞行微管相关蛋白2(MAP2)免疫荧光染色,然后利用荧光显微镜观察神经元胞体和突起的变化情况。器官型培养的DRG在电子显微镜下观察其超微结构的改变。经HIVgp120处理的神经元突起的数目和长度的变化,HIVgp120处理组与对照组相比有显著性意义(P<0.001),而神经元的直径则没有变化(P>0.05)。应用以上不同浓度的HIVgp120处理后,神经元的超微结构出现明显改变,线粒体嵴减少或消失,微管和神经丝之间出现了大量的高电子密度颗粒。以上结果表明,HIVgp120对培养的DRG神经元具有直接的神经毒性作用,其中以线粒体的改变较为敏感。 To investigate the neurotoxic effect of human immunodeficiency virus (HIV) gp120 on cultured dorsal root ganglion (DRG) neurons in vitro, dissociated and organotypic mouse embryo's DRG cell culture models were established. Both dissociated and organotypic DRG cultures were treated with HIV gp120 in different concentration (250 pmol/L and 1 nmol/L, respectively, 2 times/7 days). For dissociated DRG cultural cells, microtubule-associated protein 2 ( MAP2 ) immunofluorescent labeling was processed for observing the changes of neuronal cell body and neurites. The change of the uhrastructure in the organotypic cultured DRG was observed by electron microscopy. The difference of the number and length of neurites between the control group and HIV gp120 treated groups were significant ( P 〈 0. 001 ), whereas there was no significant difference in the diameter of neurons between them ( P 〉0.05 ). The ultrastructural changes included the decrease or loss of cristae in mitocbondria and accumulation of many high densed particles between the microtubules and the neurofilaments by using both the concentrations of HIV gp120 treatment. The present results indicate that HIV gp120 had a directly neurotoxic effect on the cultured DRG neurons, especially more sensitive to mitocbondria.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2006年第6期603-608,共6页 Chinese Journal of Neuroanatomy
基金 教育部留学回国人员科研启动基金(外教司留[2003]406号) 山东省优秀中青年科学家奖励基金(02BS091)资助项目
关键词 人类免疫缺陷病毒HIV GP120 神经元背根神经节 大鼠 human immunodeficiency virus, HIV gp120, neuron, dorsal root ganglia, rat
  • 相关文献

参考文献12

  • 1Verma A.Epidemiology and clinical features of HIV-1 associated neuropathies.J Peripher Nerv Syst,2001 ;6:8-13
  • 2Wulff EA,Wang AK,Simpson DM.HIV-associated peripheral neuropathy:epidemiology,pathophysiology and treatment.Drugs,2000 ;59:1251-1260
  • 3Brannagan TH 3rd,Nuovo GJ,Hays AP et al.Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization.Ann Neurol,1997 ;42:368 -372
  • 4Pardo CA,McArthur JC,Griffin JW.HIV neuropathy:insights in the pathology of HIV peripheral nerve disease.J Peripher Nerv Syst,2001 ;6:21 -27
  • 5Apostolski S,McAlarney T,Hays AP et al.Complement dependent cytotoxicity of sensory ganglion neurons mediated by gp120 glycoprotein of HIV-1.Immunol Invest,1994 ;23:47 -52
  • 6Oh SB,Tran PB,Gillard SE et al.Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons.J Neurosci,2001 ;21:5027-5035
  • 7Apostolski S,McAlarney T,Quattrini A et al.The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons.Ann Neurol,1993 ;34:855-863
  • 8Hu S,Sheng WS,Lokensgard JR et al.Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.J Infect Dis,2005; 191:886-889
  • 9Birge RB,Wadsworth S,Akakura R et al.A role for Schwann cells in the neuroregenerative effects of a non-immunosuppressive fk506derivative,jnj460.Neuroscience,2004; 124:351-366
  • 10Liu N,Varma S,Shooter EM et al.Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture.J Neurosci Res,2005 ;79:310-317

同被引文献17

  • 1许珊丹,曾婧,陈冠民,李汝霖.神经生长因子在周围神经系统疾病中的临床应用[J].中国新药杂志,2004,13(7):587-589. 被引量:9
  • 2刘宝贵,刘静,李秀金,王亚男,张子宁,刁莹莹,代娣,姜拥军,尚红.吉林市HIV/AIDS患者病程及抗病毒效果评价[J].中国公共卫生,2005,21(11):1291-1293. 被引量:1
  • 3蔡卫平,陈谐捷,陈劲峰,唐小平,谭俊.去羟肌苷、司他夫定联合奈韦拉平治疗艾滋病患者临床观察[J].中华传染病杂志,2006,24(1):39-43. 被引量:5
  • 4Evans SR, Ellis RJ, Chen H, et al. Peripheral neuropathy in HIV: prevalence and risk factors[ J ]. AIDS ,2011,25 (7) :919 - 928.
  • 5Schifitto G, McDermott MP, McArthur JC, et al. Markers of immune activation and viral load in HIV -associated sensory neuropathy[ J ]. Neurology ,2005,64 ( 5 ) :842 - 848.
  • 6Ellis ILl, Rosario D, Clifford DB, et al. Continued high prevalence and adverse clinical impact of human imnmnodeficiency virus - associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study [ J ]. Arch Neurol,2010,67 (5) :552 - 558.
  • 7Monroe A. Understanding and managing peripheral neuropathy [ J 1. BETA,2010,22(2) :27 -35.
  • 8Huisman MT, Smit JW, Schinkel AH. Significance of P - glycoprotein for the pharmacology and clinical use of HIV protease inhibitors[ J]. AIDS ,2000,14 ( 3 ) :237 - 242.
  • 9Swanson B, Ze||er JM, Paice JA. HIV - associated dislal symmetrical polyneuropathy : clinical features and nursing management [ J ]. J As- soc Nurses AIDS Care, 1998,9 ( 2 ) :77 - 80.
  • 10Osio M,Zampini L, Muscia F, et al. Cutaneous silent period in hu- man immunodeficiency virus - related peripheral neuropathy [ J ]. J Peripher Nerv Syst, 2004,9 (4) :224 - 231.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部